DEEP-VEIN THROMBOSIS - PREVALENCE OF ETIOLOGIC FACTORS AND RESULTS OF MANAGEMENT IN 100 CONSECUTIVE PATIENTS

被引：65
作者：
BICK, RL
JAKWAY, J
BAKER, WF
机构：
[1] UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT MED,DIV HEMATOL ONCOL,BAKERSFIELD,CA
[2] UNIV CALIF LOS ANGELES,CTR HLTH SCI,REG CANC & BLOOD DIS CTR KERN,BAKERSFIELD,CA
来源：
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1992年 / 18卷 / 02期
关键词：
D O I：
10.1055/s-2007-1002434
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：267 / 274
页数：8
相关论文
共 79 条
[1]   ASSAY OF DERMATAN SULFATE COFACTOR (HEPARIN COFACTOR-II) ACTIVITY IN HUMAN-PLASMA [J].
ABILDGAARD, U ;
LARSEN, ML .
THROMBOSIS RESEARCH, 1984, 35 (03) :257-266
[2]   SUBCUTANEOUS ADMINISTRATION OF HEPARIN - A RANDOMIZED COMPARISON WITH INTRAVENOUS ADMINISTRATION OF HEPARIN TO PATIENTS WITH DEEP-VEIN THROMBOSIS [J].
ANDERSSON, G ;
FAGRELL, B ;
HOLMGREN, K ;
JOHNSSON, H ;
LJUNGBERG, B ;
NILSSON, E ;
WILHELMSSON, S ;
ZETTERQUIST, S .
THROMBOSIS RESEARCH, 1982, 27 (06) :631-639
[3]   ANTICARDIOLIPIN ANTIBODIES - CLINICAL ASSOCIATIONS [J].
ASHERSON, RA ;
HARRIS, EN .
POSTGRADUATE MEDICAL JOURNAL, 1986, 62 (734) :1081-1087
[4]  
BANEZ EI, 1980, AM J CLIN PATHOL, V74, P569
[5]   PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
BASU, D ;
CADE, J ;
GALLUS, A ;
HIRSH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) :324-+
[6]  
BENTAL O, 1989, THROMB HAEMOSTASIS, V61, P50
[7]   AN OBJECTIVE STUDY OF ALTERNATIVE METHODS OF HEPARIN ADMINISTRATION [J].
BENTLEY, PG ;
KAKKAR, VV ;
SCULLY, MF ;
MACGREGOR, IR ;
WEBB, P ;
CHAN, P ;
JONES, N .
THROMBOSIS RESEARCH, 1980, 18 (1-2) :177-187
[8]  
BERK PD, 1986, SEMIN HEMATOL, V23, P132
[9]  
Bick R. L., 1992, DISORDERS THROMBOSIS
[10]   CLINICAL RELEVANCE OF ANTI-THROMBIN-III [J].
BICK, RL .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1982, 8 (04) :276-287
12345678